/Companies

retinalscreenings

1 known investors

Find your way into retinalscreenings

Sign up to find every way you can get introduced to retinalscreenings

  • Your email: who you already know at retinalscreenings, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the retinalscreenings team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

IRIS is cloud-based, camera-agnostic retinal screening software that lets healthcare providers capture, enhance, and diagnose diabetic retinopathy, with board-certified eye specialists interpreting the images. It serves hospitals, health systems, federally qualified health centers, health plans, labs, pharmacies, and health risk assessment companies to close care gaps and reduce costs.

Investors · 1

Frequently asked questions

What does retinalscreenings do?
IRIS is cloud-based, camera-agnostic retinal screening software that lets healthcare providers capture, enhance, and diagnose diabetic retinopathy, with board-certified eye specialists interpreting the images. It serves hospitals, health systems, federally qualified health centers, health plans, labs, pharmacies, and health risk assessment companies to close care gaps and reduce costs.
Who are retinalscreenings's investors?
retinalscreenings's investors include Florida Technology Seed Capital Fund.